Skip to main content
. 2020 Nov 19;10(11):974. doi: 10.3390/diagnostics10110974

Figure 4.

Figure 4

Viral load and serum chemerin during DAA therapy. (A) Viral load before (0), 4 and 12 weeks after start of therapy (AS), and 12 weeks after end of therapy (AE); (B) correlation of chemerin at the start of DAA therapy and change of viral load within 4 weeks of treatment; (C) chemerin at the times described in (A). Small circles or asterisks above the boxes mark outliers. *** p < 0.001.